Reduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation.
Burke, S E
Reduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation. [electronic resource] - Journal of cardiovascular pharmacology Oct 1992 - 619-29 p. digital
Publication Type: Journal Article
0160-2446
10.1097/00005344-199210000-00016 doi
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacokinetics
Coronary Circulation--drug effects
Dogs
Free Radicals--metabolism
Hemodynamics--drug effects
In Vitro Techniques
Inflammation--drug therapy
Male
Myocardial Infarction--drug therapy
Myocardium--pathology
Neutrophils--drug effects
Phagocytosis--drug effects
Tetrazoles--pharmacokinetics
Thiophenes--pharmacokinetics
Ventricular Fibrillation--physiopathology
Reduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation. [electronic resource] - Journal of cardiovascular pharmacology Oct 1992 - 619-29 p. digital
Publication Type: Journal Article
0160-2446
10.1097/00005344-199210000-00016 doi
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacokinetics
Coronary Circulation--drug effects
Dogs
Free Radicals--metabolism
Hemodynamics--drug effects
In Vitro Techniques
Inflammation--drug therapy
Male
Myocardial Infarction--drug therapy
Myocardium--pathology
Neutrophils--drug effects
Phagocytosis--drug effects
Tetrazoles--pharmacokinetics
Thiophenes--pharmacokinetics
Ventricular Fibrillation--physiopathology